The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 183, 4968 -4974
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0900907

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Yu, J.
Right arrow Articles by Caligiuri, M. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, J.
Right arrow Articles by Caligiuri, M. A.
Right arrowPubmed/NCBI databases
*Substance via MeSH

CD94 Defines Phenotypically and Functionally Distinct Mouse NK Cell Subsets1

Jianhua Yu,2*{dagger} Min Wei,* Hsiaoyin Mao,* Jianying Zhang,{ddagger} Tiffany Hughes,* Takeki Mitsui,* Il-kyoo Park,* Christine Hwang,* Shujun Liu,*{dagger} Guido Marcucci,*{dagger}§ Rossana Trotta,*{dagger} Don M. Benson, Jr.,*{dagger} and Michael A. Caligiuri2*{dagger}§

*Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210; {dagger}Division of Hematology/Oncology, Department of Internal Medicine, The Ohio State Universit0y, Columbus, OH 43210; {ddagger}Center for Biostatistics, The Ohio State University, Columbus, OH 43210; and §The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, Columbus, OH 43210

Understanding of heterogeneous NK subsets is important for the study of NK cell biology and development, and for the application of NK cell-based therapies in the treatment of disease. Here we demonstrate that the surface expression of CD94 can distinctively divide mouse NK cells into two approximately even CD94low and CD94high subsets in all tested organs and tissues. The CD94high NK subset has significantly greater capacity to proliferate, produce IFN-{gamma}, and lyse target cells than does the CD94low subset. The CD94high subset has exclusive expression of NKG2A/C/E, higher expression of CD117 and CD69, and lower expression of Ly49D (activating) and Ly49G2 (inhibitory). In vivo, purified mouse CD94low NK cells become CD94high NK cells, but not vice versa. Collectively, our data suggest that CD94 is an Ag that can be used to identify functionally distinct NK cell subsets in mice and could also be relevant to late-stage mouse NK cell development.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Cancer Institute Grants CA95426 and CA68458 (to M.A.C).

2 Address correspondence and reprint requests to Dr. Michael A. Caligiuri or Dr. Jianhua Yu, Ohio State University, 300 West 10th Avenue, Suite 521C, Columbus, OH 43210. E-mail address: michael.caligiuri{at}osumc.edu or jianhua.yu{at}osumc.edu

3 Abbreviations used in this paper: WT, wild type; mIL-12, murine IL-12.

4 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.